Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. a possible mechanism of action of the intrauterine device
Archer, D.F.; DeSoto, K.R.; Baker, J.M.
Contraception 59(3): 175-179
1999
ISSN/ISBN: 0010-7824 PMID: 10382080 DOI: 10.1016/s0010-7824(99)00014-1Document Number: 533137
This paper examines the possible mechanism of action of a progesterone-releasing IUD (P-IUD) by evaluating the concentration of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in the intrauterine fluid of postmenopausal women using such a device. IL-6 and TNF-alpha were examined using an enzyme-linked immunosorbent assay (ELISA), while the intrauterine fluid was obtained by lavage. Intrauterine fluid IL-6 levels were 33.6 vs. 6.09 pg/sample for P-IUD vs. non-P-IUD users (p = 0.0301). Higher intrauterine TNF-alpha levels were observed in women using the P-IUD than in nonusers. The cells found in the intrauterine fluid of the P-IUD users were mostly histiocytes (macrophages) based on their morphologic characteristics. Increased IL-6 and TNF-alpha levels were found in the intrauterine cavity of postmenopausal women using a P-IUD. These results indicate that cytokines could play a significant role in the contraceptive mechanism of action of the IUD when used by premenopausal women.